Drugs that contain Indocyanine Green
1. Spy Agent Green Kit patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9421280 | NOVADAQ TECH | Real time imaging during solid organ transplant |
Nov, 2025
(1 year, 11 months from now) | |
| US8185176 | NOVADAQ TECH | Method and apparatus for vasculature visualization with applications in neurosurgery and neurology |
Jun, 2028
(4 years from now) | |
| US8647605 | NOVADAQ TECH | Real time imaging during solid organ transplant |
Feb, 2029
(5 years from now) | |
| US8406860 | NOVADAQ TECH | Method for evaluating blush in myocardial tissue |
Apr, 2029
(5 years from now) | |
| US10631746 | NOVADAQ TECH | Quantification of absolute blood flow in tissue using fluorescence-mediated photoplethysmography |
Aug, 2035
(11 years from now) | |
| US11712320 | NOVADAQ TECH | Methods and systems to automate surgical interventions |
Jul, 2039
(15 years from now) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Indication (I) | Jun 5, 2026 |
Market Authorisation Date: 21 November, 2018
Treatment: Visualization of vessels, blood flow and tissue perfusion of donor organ or attached vessel in vascular, gastrointestinal, organ transplant, and plastic, micro- and reconstructive, including minimally...
Dosage: POWDER;INTRAVENOUS, INTERSTITIAL
How can I launch a generic of SPY AGENT GREEN KIT before it's drug patent expiration?
More Information on Dosage
SPY AGENT GREEN KIT family patents
